StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.98+0.01 (+0.51%)

Close on Nov 17, 2026Market cap $160.90MP/E –Yield –

Eledon Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Eledon Pharmaceuticals's operating income for the twelve months ending Sep 30, 2024 was -$56.22M. For fiscal 2023 it was -$43.00M. The highest annual figure on record is -$5.13M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$43.00M–
FY2022Dec 31, 2022-$88.43M–
FY2021Dec 31, 2021-$36.87M–
FY2020Dec 31, 2020-$18.47M–
FY2019Dec 31, 2019-$16.05M–
FY2018Dec 31, 2018-$14.06M–
FY2017Dec 31, 2017-$13.12M–
FY2016Dec 31, 2016-$5.13M–
FY2015Dec 31, 2015-$45.26M–
FY2014Dec 31, 2014-$23.46M–
FY2013Dec 31, 2013-$15.75M–
FY2012Dec 31, 2012-$9.65M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.87M–
Q1 FY2026Mar 31, 2026-$21.18M–
Q3 FY2025Sep 30, 2025-$19.07M–
Q2 FY2025Jun 30, 2025-$24.73M–
Q1 FY2025Mar 31, 2025-$17.96M–
Q3 FY2024Sep 30, 2024-$20.51M–
Q2 FY2024Jun 30, 2024-$14.50M–
Q1 FY2024Mar 31, 2024-$10.87M–
Q4 FY2023Dec 31, 2023-$10.34M–
Q3 FY2023Sep 30, 2023-$11.20M–
Q2 FY2023Jun 30, 2023-$10.35M–
Q1 FY2023Mar 31, 2023-$11.11M–
Q4 FY2022Dec 31, 2022-$58.69M–
Q3 FY2022Sep 30, 2022-$10.60M–
Q2 FY2022Jun 30, 2022-$9.28M–
Q1 FY2022Mar 31, 2022-$9.86M–
Q4 FY2021Dec 31, 2021-$9.39M–
Q3 FY2021Sep 30, 2021-$10.51M–
Q2 FY2021Jun 30, 2021-$7.97M–
Q1 FY2021Mar 31, 2021-$9.01M–
Q4 FY2020Dec 31, 2020-$6.35M–
Q3 FY2020Sep 30, 2020-$6.15M–
Q2 FY2020Jun 30, 2020-$2.59M–
Q1 FY2020Mar 31, 2020-$3.38M–
Q4 FY2019Dec 31, 2019-$4.17M–
Q3 FY2019Sep 30, 2019-$2.92M–
Q2 FY2019Jun 30, 2019-$4.09M–
Q1 FY2019Mar 31, 2019-$4.88M–
Q4 FY2018Dec 31, 2018-$4.58M–
Q3 FY2018Sep 30, 2018-$3.50M–
Q2 FY2018Jun 30, 2018-$3.19M–
Q1 FY2018Mar 31, 2018-$2.80M–
Q4 FY2017Dec 31, 2017-$2.11M–
Q3 FY2017Sep 30, 2017-$2.97M–
Q2 FY2017Jun 30, 2017-$6.67M–
Q1 FY2017Mar 31, 2017-$1.39M–
Q4 FY2016Dec 31, 2016-$3.76M–
Q3 FY2016Sep 30, 2016-$1.62M–

More Eledon Pharmaceuticals figures

See a number that looks wrong?